Market Overview

Illumina Signs Master Supply Agreement with LabCorp

Share:
Related ILMN
What Passage Of The 21st Century Cures Act Means For Biotech Stocks
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
The Vetr community has upgraded $ILMN to 4.5-Stars. (Vetr)

Illumina (NASDAQ: ILMN) today announced it has entered into a
multi-year supply agreement with Laboratory Corporation of America®
Holdings (LabCorp®) (NYSE: LH). The agreement gives LabCorp expanded
rights to use Illumina next-generation sequencing (NGS) and microarray
equipment and supplies to develop, validate and introduce
laboratory-developed tests to clinicians in the United States and Canada.

See full press release

Posted-In: News Guidance Offerings Contracts Management Global

 

Related Articles (ILMN + LH)

View Comments and Join the Discussion!